C62.12
Malignant neoplasm of descended left testis
Clinical Classification Guidelines
Medical Intelligence & Overview
Malignant neoplasm of the descended left testis, classified under ICD-10 code C62.12, refers to cancer that develops in the testis of the left side that has properly descended into the scrotum. Testicular cancer is a rare form of cancer, but it is the most common solid malignancy in males aged 15 to 35. Early diagnosis and treatment are critical for successful outcomes. This article provides an overview of the causes, symptoms, diagnosis, and treatment options for this condition, aiming to educate and inform.
Causes & Symptoms
Clinical Causes: Genetic factors, including family history of testicular cancer Undescended testicle (cryptorchidism) during childhood Personal history of testicular cancer in the other testis Certain inherited disorders that affect testicular development Age-related factors, predominantly affecting young and middle-aged men History of testicular trauma or injury, though rare
Key Symptoms: A painless lump or swelling in the testicle A feeling of heaviness or discomfort in the scrotum A sudden collection of fluid in the scrotum Pain or discomfort in the testis or scrotum A dull ache in the groin or lower abdomen Changes in the size or shape of the testicle Sensation of dragging or pulling in the scrotal area
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves several key steps to confirm the presence of cancer and determine its extent. These include: - **Physical Examination:** A healthcare provider examines the testicles for lumps, swelling, or other abnormalities. - **Ultrasound Imaging:** A scrotal ultrasound helps distinguish between benign and malignant masses. - **Blood Tests:** Tumor markers such as alpha-fetoprotein (AFP), human chorionic gonadotropin (HCG), and lactate dehydrogenase (LDH) are examined for abnormal levels. - **Imaging Studies:** Chest X-rays, computed tomography (CT) scans, or positron emission tomography (PET) scans may be used to check for metastasis. - **Biopsy:** Usually, a surgical removal of the testicle (orchiectomy) is performed for definitive diagnosis and to determine the cancer type.
Treatment Protocols: Treatment strategies depend on the cancer stage and type but often include: - **Surgical Removal:** Orchiectomy, which involves removing the affected testicle, typically serves as the initial treatment. - **Radiation Therapy:** May be used, especially in certain types of testicular cancer, to target remaining cancer cells. - **Chemotherapy:** Systemic treatment is common when the cancer has spread beyond the testicle. - **Surveillance:** Regular follow-up appointments and imaging to monitor for recurrence. - **Additional Therapies:** In some cases, retroperitoneal lymph node dissection (RPLND) might be necessary to remove cancerous lymph nodes. Prognosis often improves with early detection, and many patients recover fully with appropriate treatment.
Clinical Advice & FAQs
Billing Guidance
Is C62.12 a billable ICD-10 code?
Yes, C62.12 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C62.12?
Clinical documentation must specify the nature of Malignant neoplasm of descended left testis and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
